We serve Chemical Name:2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole CAS:173406-59-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole
CAS.NO:173406-59-2
Synonyms:2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole
Molecular Formula:C9H7BrN2S
Molecular Weight:255.13400
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:366.8ºC at 760 mmHg
Density:1.564g/cm3
Index of Refraction:1.628
PSA:54.02000
Exact Mass:253.95100
LogP:3.27600
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole Use and application,2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole technical grade,usp/ep/jp grade.
Related News: A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus. 2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole manufacturer The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. 2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole supplier The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. 2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole vendor First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. 2-(3-bromophenyl)-5-methyl-1,3,4-thiadiazole factory Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged.
